News
Here's Why Tetra (TTEK) Is a Great 'Buy the Bottom' Stock Now
Shares of Tetra Tech (TTEK) have been struggling lately and have lost 9.6% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock
Frontdoor (FTDR) Q4 Earnings and Revenues Surpass Estimates
Frontdoor (FTDR) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.27 per share a year ago. These figures
GigaCloud Technology Inc. (GCT) Surpasses Q4 Earnings and Revenue Estimates
GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.76 per share a year ago
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.18 per share a year ago
Suzuki Motor (SZKMY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
The price trend for Suzuki Motor (SZKMY) has been bearish lately and the stock has lost 5.5% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session
Wall Street Analysts Think Tactile Systems Technology (TCMD) Could Surge 28.34%: Read This Before Placing a Bet
Shares of Tactile Systems Technology (TCMD) have gained 3.4% over the past four weeks to close the last trading session at $29.61, but there could still be a solid upside left in the stock if
Bentley Systems, Incorporated (BSY) Q4 Earnings Meet Estimates
Bentley Systems, Incorporated (BSY) came out with quarterly earnings of $0.27 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.21 per share a year ago. These
Wall Street Analysts Believe Oric Pharmaceuticals (ORIC) Could Rally 58.43%: Here's is How to Trade
Shares of Oric Pharmaceuticals, Inc. (ORIC) have gained 22% over the past four weeks to close the last trading session at $13.4, but there could still be a solid upside left in the stock if
RE/MAX (RMAX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in RE/MAX (RMAX) lately. While the stock has lost 5.6% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading
Krispy Kreme (DNUT) Tops Q4 Earnings and Revenue Estimates
Krispy Kreme (DNUT) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.01 per share a year ago. These
After Golden Cross, CMS Energy (CMS)'s Technical Outlook is Bright
From a technical perspective, CMS Energy Corporation (CMS) is looking like an interesting pick, as it just reached a key level of support. CMS's 50-day simple moving average crossed above its
Here's Why Gossamer Bio (GOSS) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in Gossamer Bio (GOSS) lately. While the stock has lost 82.5% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last
Wall Street Analysts Think Palomar (PLMR) Could Surge 36.15%: Read This Before Placing a Bet
Shares of Palomar (PLMR) have gained 1.7% over the past four weeks to close the last trading session at $121.68, but there could still be a solid upside left in the stock if short-term price targets
Huron Consulting (HURN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Shares of Huron Consulting (HURN) have been struggling lately and have lost 21.2% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean
Ormat Technologies Q4 Earnings Meet Estimates, Revenues Beat
Ormat Technologies Inc. ORA reported fourth-quarter 2025 adjusted earnings per share of 67 cents, which came in line with the Zacks Consensus Estimate. However, the bottom line decreased 6.9% from
ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
Acadia Pharmaceuticals ACAD reported fourth-quarter 2025 earnings per share (EPS) of 16 cents (excluding tax benefit), which beat the Zacks Consensus Estimate of 12 cents. In the year-ago quarter
HEICO Q1 Earnings Surpass Estimates, Sales Increase Y/Y
HEICO Corporation HEI reported first-quarter fiscal 2026 earnings per share (EPS) of $1.35, which beat the Zacks Consensus Estimate of $1.26 by 7.1%. The bottom line also improved 12.5% from the
Here's Why RingCentral (RNG) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Plains All American Pipeline (PAA) is a Top-Ranked Momentum Stock: Should You Buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Here's Why United Airlines (UAL) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why Infineon Technologies AG (IFNNY) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Global Payments (GPN) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why M&T Bank Corporation (MTB) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Corpay (CPAY) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates


